144 related articles for article (PubMed ID: 30788715)
1. Evaluating Dissemination of Adequate Lymphadenectomy for Gastric Cancer in the USA.
Villano AM; Zeymo A; McDermott J; Crocker A; Zeck J; Chan KS; Shara N; Kim S; Al-Refaie WB
J Gastrointest Surg; 2019 Nov; 23(11):2119-2128. PubMed ID: 30788715
[TBL] [Abstract][Full Text] [Related]
2. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
3. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
Tee MC; Pirozzi N; Brahmbhatt RD; Raman S; Franko J
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1941-1947. PubMed ID: 32466860
[TBL] [Abstract][Full Text] [Related]
4. Variations in gastric cancer care: a trend beyond racial disparities.
Al-Refaie WB; Gay G; Virnig BA; Tseng JF; Stewart A; Vickers SM; Tuttle TM; Feig BW
Cancer; 2010 Jan; 116(2):465-75. PubMed ID: 19950130
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma.
Schoenleber SJ; Schnelldorfer T; Wood CM; Qin R; Sarr MG; Donohue JH
J Gastrointest Surg; 2009 Jul; 13(7):1233-7. PubMed ID: 19367436
[TBL] [Abstract][Full Text] [Related]
7. Gastric Cancer Surgery in the US: a Contemporary Trend Analysis of Lymphadenectomy and the Impact of Minimally Invasive Approaches.
Maegawa FB; Patel AD; Serrot FJ; Patel SG; Stetler JL; Patel DC; Ghaderi I; Hsu CH; Ashouri Y; Sarmiento JM; Konstantinidis IT; Lin E
J Gastrointest Surg; 2023 Sep; 27(9):1825-1836. PubMed ID: 37340110
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Lymph Node Metastasis Among Adults With Gastric Adenocarcinoma Managed With Total Gastrectomy.
Khalayleh H; Kim YW; Man Yoon H; Ryu KW; Kook MC
JAMA Netw Open; 2021 Feb; 4(2):e2035810. PubMed ID: 33566106
[TBL] [Abstract][Full Text] [Related]
10. D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival.
Wohnrath DR; Araujo RLC
Eur J Surg Oncol; 2019 Mar; 45(3):446-453. PubMed ID: 30392746
[TBL] [Abstract][Full Text] [Related]
11. Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer.
Harrison LE; Karpeh MS; Brennan MF
J Gastrointest Surg; 1998; 2(2):126-31. PubMed ID: 9834407
[TBL] [Abstract][Full Text] [Related]
12. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
13. Benchmarks for nodal yield and ratio for node-positive gastric cancer.
Erstad DJ; Blum M; Estrella JS; Das P; Minsky BD; Ajani JA; Mansfield PF; Ikoma N; Badgwell BD
Surgery; 2021 Oct; 170(4):1231-1239. PubMed ID: 34059344
[TBL] [Abstract][Full Text] [Related]
14. Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer.
Ikoma N; Blum M; Chiang YJ; Estrella JS; Roy-Chowdhuri S; Fournier K; Mansfield P; Ajani J; Badgwell BD
Ann Surg Oncol; 2017 Apr; 24(4):960-965. PubMed ID: 27778127
[TBL] [Abstract][Full Text] [Related]
15. Nativity, complications, and pathology are determinants of surgical results for gastric cancer.
Fortner JG; Lauwers GY; Thaler HT; Concepcion R; Friedlander-Klar H; Kher U; Maclean BJ
Cancer; 1994 Jan; 73(1):8-14. PubMed ID: 8275442
[TBL] [Abstract][Full Text] [Related]
16. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.
Maduekwe UN; Lauwers GY; Fernandez-Del-Castillo C; Berger DL; Ferguson CM; Rattner DW; Yoon SS
Ann Surg Oncol; 2010 May; 17(5):1267-77. PubMed ID: 20099040
[TBL] [Abstract][Full Text] [Related]
17. Analysis of risk factors of stage IV gastric cancer from the SEER database.
Ge XY; Ge F; Wang Z; Wang YL; Lei LW; Liu QR; Sun XY; Jiang X
Ann R Coll Surg Engl; 2020 May; 102(5):355-362. PubMed ID: 32326735
[TBL] [Abstract][Full Text] [Related]
18. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
[TBL] [Abstract][Full Text] [Related]
19. Lymphadenectomy in patients with gastric cancer. A critical review.
Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
[TBL] [Abstract][Full Text] [Related]
20. Race/Ethnicity is predictive of lymph node status in patients with early gastric cancer.
Fukuhara S; Yabe M; Montgomery MM; Itagaki S; Brower ST; Karpeh MS
J Gastrointest Surg; 2014 Oct; 18(10):1744-51. PubMed ID: 25060552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
